Skip to main content
. 2019 Mar 3;2019:2673543. doi: 10.1155/2019/2673543

Table 1.

DNA methylation biomarkers in detecting colorectal cancer.

Methylated gene Sample type Detecting method No. of patients Sensitivity No. of controls Specificity P value for prognosis∗∗ Reference
SEPT9 Blood qPCR 90 75.6% NA NA NA [16]
Serum qMSP 150 NA NA NA P < 0.05 [13]
TWIST1 Tissue MSP 319 55.7% 215 100% NA [17]
Plasma MSP 353 70.0% NA NA P > 0.1 [18]
RUNX3 Tissue MSP 30 28% 30 85% NA [19]
Tissue MSP 62 32.3% 10 100% P = 0.038 [20]
Serum MSP 65 41.5% NA NA NA [21]
Serum MSP 344 29% 56 100% P = 0.0003 [22]
Tissue MSP 119 39% NA NA NA [22]
TAC1 Tissue MSP 34 47% 17 88% NA [23]
Serum qMSP 150 NA NA NA P ≤ 0.001 [13]
Serum MSP 165 NA NA NA P = 0.612 [24]
Serum MSP 193 NA NA NA P = 0.047 [25]
IGFBP3 Tissue qMSP 425 44.9% 21 NA NA [14]
Tissue MSP 147 NA NA NA P < 0.05 [26]
Tissue MSP 115 NA NA NA P = 0.004 [27]
EYA4 Tissue MSP 46 93.5% 46 67.4% NA [15]
Stool MSP 13 100% 19 94.7% NA [15]
Serum qMSP 26 57.7% 26 ≥90% NA [28]
Serum qMSP 150 NA NA NA P > 0.05 [13]
SST Tissue MSP 34 88% 17 53% NA [23]
Serum qMSP 150 NA NA NA P < 0.05 [13]
Serum MSP 165 NA NA NA P < 0.05 [24]

Sensitivity refers to the hypermethylation rates in colorectal cancer samples, while specificity refers to the opposite rates in normal samples. ∗∗P value for association of DNA hypermethylation with poorer prognosis, including cancer recurrence and reduced survival. SEPT9: methylated septin 9; TWIST1: twist-related protein 1; RUNX3: runt-related transcription factor 3; TAC1: tachykinin-1; IGFBP3: insulin-like growth factor binding protein 3; EYA4: eyes absent homolog 4; qPCR: quantitative polymerase chain reaction; qMSP: quantitative methylation-specific PCR; SST: somatostatin; NA: not available.